In a sign of Congress’ growing recognition of the importance of San Diego’s world-leading biotech community, Congressman Peter Roskam (R-IL), Chief Deputy Whip and fourth ranking Republican of the House of Representatives, toured Pathway Genomics and visited with leaders of San Diego’s biotech community.
“I was very impressed. San Diego’s biotech community is indeed leading the world. Every day it becomes more and more important to our nation’s economy and balance of trade,” said Roskam. “It’s critical that Congress works with the private sector to enact policies that support and encourage this kind of revolutionary innovation, and protect public safety.”
The event was held last week at Pathway’s corporate headquarters in San Diego and included a tour of its state-of-the-art laboratory, which is certified by the federal government, licensed by the state of California, and was recently accredited by the respected College of American Pathologists (CAP).
“It’s critical that Congress works with the private sector to enact policies that support and encourage this kind of revolutionary innovation, and protect public safety,” said Congressman Roskam.
“Maintaining an open dialogue between lawmakers and members of the biotech community is vital to the growth of the industry,” said Jim Plante, founder and CEO of Pathway Genomics. “Congressman Roskam clearly recognizes the vast potential the field of genetics has to improve lives, and personalize the delivery of healthcare.”
Roskam’s visit follows a trip by Plante to Washington, D.C., where he met with the Speaker of the House John Boehner, House Majority Leader Eric Cantor, and Congressman Roskam to talk about what the biotech industry needs from Congress. Roskam’s trip to Pathway demonstrates the leadership’s efforts to help the job creators in our society.
“We have unlimited potential here, both for the economy and to improve the quality of life in America,” said Joe Panetta, president and CEO of BIOCOM. “By working together, the United States is well-positioned to solidify its position as the worldwide leader in this fast-growing economic sector, and create tens of thousands of high-wage ‘green’ jobs.”
Congressman Roskam’s visit to Pathway comes at an exciting and developing time for the field of genetic testing, and it illustrates the company’s commitment to promote collaboration between industry leaders and the federal government. Pathway plans to continue active involvement with U.S. politicians to help build a road to success for the country’s job growth, innovation, and rapidly growing field of personalized health care.